课题基金 / 基金详情

MARROW GRAFT FAILURE IN ALLOGENIC BONE MARROW TRANSPLANTATION

MARROW GRAFT FAILURE IN ALLOGENIC BONE MARROW TRANSPLANTATION
同种异体骨髓移植中的骨髓移植失败
批准号:
3813477
负责人:
R E GRESS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

R E GRESS的其他基金

相似基金

相关文献

中文摘要
翻译
许多观察表明,宿主淋巴细胞,特别是
英文摘要
A number of observations have suggested that host lymphocytes, specifically cytotoxic T cells (CTL) may play a significant role in mediating allogeneic marrow graft rejection. In a murine model system, CTL were cloned from the spleens of sublethally irradiated animals which had rejected MHC disparate marrow grafts. It was found that cloned CTL were sufficient to effect rejection of T cell depleted allogeneic marrow in lethally irradiated animals. The rejection of marrow grafts by CTL was specific for the MHC gene products expressed by the marrow cells and correlated with the cytotoxic specificity of the individual clones. Since CTL can therefore reject marrow grafts, the administration of anti-CD3 monoclonal antibody in vivo has been studied as a means to enhance engraftment of T cell depleted marrow in sublethally irradiated murine hosts. In addition, cells capable of specifically suppressing precursor CTL have been studied in vitro and in vivo. In order to similarly evaluate human CTL, xenospecific human cytotoxic responses have been studied. The fine specificity of xenoantigen recognition by human T cells suggests that in transplantation of xenogeneic tissue, as in transplantation of MHC mismatched allogeneic tissue, the particular tissue antigens, and therefore tissue typing, may be a relevant consideration. The generation of human CTL has been characterized and certain essential cellular interactions in that generation have been identified.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GRAFT REJECTION--CELLULAR & CYTOKINE REGULARION OF TRANSPLANTATION RESPONSES
T CELL FUNCTION IN T CELL DEPLETED STATES
T CELL FUNCTION IN T CELL DEPLETED BONE MARROW TRANSPLANTATION
MARROW GRAFT REJECTION IN ALLOGENEIC BONE MARROW TRANSPLANTATION
海外基金